Cameron Kevin J 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Jun 19, 2018
Insider Transaction Report
Form 4
Cameron Kevin J
Director
Transactions
- Sale
Common Stock
2018-06-18$4.98/sh−1,667$8,302→ 176,666 total
Footnotes (2)
- [F1]Sale of a total of 1,667 shares of common stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017.
- [F2]Includes 9,999 shares of restricted stock.